Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Trine Vang Skjøth
Comparison of a Soluble Co-Formulation of Insulin Degludec/Insulin Aspart vs Biphasic Insulin Aspart 30 in Type 2 Diabetes: A Randomised Trial
European Journal of Endocrinology
Medicine
Endocrinology
Metabolism
Diabetes
Related publications
Insulin Degludec Aspart: The First Co-Formulation of Insulin Analogues
Diabetes Therapy
Internal Medicine
Endocrinology
Metabolism
Diabetes
15 Years of Experience With Biphasic Insulin Aspart 30 in Type 2 Diabetes
Drugs in R and D
Pharmacology
Use of Biphasic Insulin Aspart 30 in Type 2 Diabetes Treatment: Expert Panel Recommendations
Turkish Journal of Endocrinology and Metabolism
Internal Medicine
Endocrinology
Metabolism
Diabetes
Initiation of Biphasic Insulin Aspart in a Patient Failing Basal Insulin Treatment
European Endocrinology
Endocrine
Endocrinology
Metabolism
Autonomic Systems
Diabetes
Fiasp: A New Faster-Acting Insulin Aspart Formulation for Diabetes
Prescriber
Pharmacology
Faster-Acting Insulin Aspart Provides Faster Onset and Greater Early Exposure vs Insulin Aspart in Children and Adolescents With Type 1 Diabetes Mellitus
Pediatric Diabetes
Internal Medicine
Pediatrics
Endocrinology
Perinatology
Child Health
Metabolism
Diabetes
Budget Impact Analysis of Biphasic Insulin Aspart in the Treatment of Type 2 Diabetes Mellitus in Malaysia: A Public Payer Perspective
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Safety and Effectiveness of Biphasic Insulin Aspart 30 in Different Age-Groups: A1chieve Sub-Analysis
Diabetes Therapy
Internal Medicine
Endocrinology
Metabolism
Diabetes
Continuous Subcutaneous Insulin Infusion (CSII) of Insulin Aspart Versus Multiple Daily Injection of Insulin Aspart/Insulin Glargine in Type 1 Diabetic Patients Previously Treated With CSII
Diabetes Care
Internal Medicine
Endocrinology
Advanced
Metabolism
Specialized Nursing
Diabetes
